BioPharm International-12-01-2016

BioPharm International

Cross Contamination in Biopharma

December 01, 2016

Troubleshooting

29

12

John Ward, vice-president of Engineering at Patheon, discusses the potential for cross contamination in the manufacture of biopharmaceuticals.

Expression systems for the development of biosimilars

December 01, 2016

Features

29

12

Andrew Bulpin, head of Process Solutions Strategic Marketing & Innovation at MilliporeSigma spoke with BioPharm International about the requirements of expression systems in biosimilar development.

Large-Scale Protein Expression in Baculovirus-Infected Insect Cells

December 01, 2016

Features

29

12

The baculovirus-insect cell system can produce large quantities of complex protein in a short period of time.

Chromatograph Enables Fast Recovery of Target Compounds

December 01, 2016

Product Spotlight

29

12

The Prominence Ultra-Fast Preparative and Purification Liquid Chromatograph (UFPLC) from Shimadzu enables fast recovery of highly purified target compounds from complex samples including organic synthesis reaction mixtures and natural products.

Pharmaceutical Manufacturers Gear Up for Political Change

December 01, 2016

Regulatory Beat

29

12

Republican control of Washington promises overhaul of healthcare and medical product regulation.

Options in Employee Training

December 01, 2016

Ask the Expert

29

12

Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses training personnel on a limited budget.

Students Teach Pharma a Lesson

December 01, 2016

From the Editor

29

12

Rookie API developers beat pharma at its own game.

BioPharm International, December 2016 Issue (PDF)

December 01, 2016

Issue PDF

29

12

Click the title above to open the BioPharm International December 2016 issue in an interactive PDF format.